A von Graevenitz. Show Affiliations »
Abstract
Mesh: See more » Ampicillin/pharmacologyAnti-Bacterial Agents/pharmacologyBacteriological TechniquesCephalothin/pharmacologyChloramphenicol/pharmacologyColistin/pharmacologyErythromycin/pharmacologyFurazolidone/pharmacologyHumansKanamycin/pharmacologyNalidixic Acid/pharmacologyNeomycin/pharmacologyNitrofurantoin/pharmacologyNitrofurazone/pharmacologyNovobiocin/pharmacologyPenicillin G/pharmacologyPenicillin ResistanceSerratia marcescens/drug effectsStreptomycin/pharmacologySulfadiazine/pharmacologyTetracycline/pharmacologyTroleandomycin/pharmacology
Substances: See more » Anti-Bacterial AgentsSulfadiazineNovobiocinNalidixic AcidKanamycinFurazolidoneErythromycinChloramphenicolAmpicillinNitrofurantoinTroleandomycinTetracyclineNeomycinPenicillin GCephalothinNitrofurazoneStreptomycinColistin
Year: 1967 PMID: 4863818 DOI: 10.1159/000220503
Source DB: PubMed Journal: Chemotherapy ISSN: 0009-3157 Impact factor: 2.544